Company Ceases Manufacture of Death Penalty Drug

Hospira Pharmaceuticals, the only American manufacturer of a drug used in U.S. executions, will cease making that drug, the company announced today.

Sodium thiopental, an anesthesia drug, is used to put inmates to sleep before two other drugs paralyze the muscles and stop the heart. There has been a shortage of sodium thiopental recently, forcing states to scramble for alternatives or delay executions. Hospira said a supply issue with the drug's active ingredient was to blame for the shortage. [Read Execution Science: What's the Best Way to Kill a Person?]

Latest Videos From
Stephanie Pappas
Live Science Contributor

Stephanie Pappas is a contributing writer for Live Science, covering topics ranging from geoscience to archaeology to the human brain and behavior. She was previously a senior writer for Live Science but is now a freelancer based in Denver, Colorado, and regularly contributes to Scientific American and The Monitor, the monthly magazine of the American Psychological Association. Stephanie received a bachelor's degree in psychology from the University of South Carolina and a graduate certificate in science communication from the University of California, Santa Cruz.